Dyne Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DYN and other ETFs, options, and stocks.

About DYN

Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. 

CEO
John G. Cox
CEOJohn G. Cox
Employees
141
Employees141
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2017
Founded2017
Employees
141
Employees141

DYN Key Statistics

Market cap
2.06B
Market cap2.06B
Price-Earnings ratio
-6.46
Price-Earnings ratio-6.46
Dividend yield
—
Dividend yield—
Average volume
820.00K
Average volume820.00K
High today
$26.33
High today$26.33
Low today
$24.83
Low today$24.83
Open price
$25.22
Open price$25.22
Volume
807.67K
Volume807.67K
52 Week high
$30.27
52 Week high$30.27
52 Week low
$6.40
52 Week low$6.40

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.